Homocysteine lowering: any use in atherosclerosis?
Príomhchruthaitheoirí: | Antoniades, C, Shirodaria, C, Stefanadis, C, Channon, K |
---|---|
Formáid: | Journal article |
Teanga: | English |
Foilsithe / Cruthaithe: |
2007
|
Míreanna comhchosúla
Míreanna comhchosúla
-
Homocysteine and coronary atherosclerosis: from folate fortification to the recent clinical trials.
de réir: Antoniades, C, et al.
Foilsithe / Cruthaithe: (2009) -
MTHFR 677 C>T Polymorphism reveals functional importance for 5-methyltetrahydrofolate, not homocysteine, in regulation of vascular redox state and endothelial function in human atherosclerosis.
de réir: Antoniades, C, et al.
Foilsithe / Cruthaithe: (2009) -
Vascular Homocysteine Versus 5-Methyl-Tetrahydrofolate As Regulators of Vascular Redox and Endothelial Function in Human Vessels
de réir: Antoniades, C, et al.
Foilsithe / Cruthaithe: (2009) -
Nanoparticles: a promising therapeutic approach in atherosclerosis.
de réir: Antoniades, C, et al.
Foilsithe / Cruthaithe: (2010) -
Plasma levels of sCD40-ligand interact with homocysteine biosynthetic pathway and predict eNOS coupling in human vessels: effects on vascular redox state
de réir: Antoniades, C, et al.
Foilsithe / Cruthaithe: (2008)